← All calculators

Continuous dialysis · Regional citrate anticoagulation

Citrate kinetics on CRRT

How much citrate does the patient keep? Enter the CVVHDF prescription to get citrate load and worst-case accumulation, then project systemic citrate by liver clearance, including a sudden loss of liver metabolism. Read the reference.

1Prescription and steady state

Citrate infused before the filter is partly removed in the effluent on the same pass; the rest returns to the patient as the citrate load. At steady state, citrate load equals removal.

Modality

Blood side

mL/min
g/dL
mL/hr
mmol/L

Effluent side

L/hr
L/hr
L/hr
Effluent QEFF2.90 L/hr

Results

Patient citrate load Gdose × (1 − Ecit)20.4mmol/hr
Worst-case CMaxNo liver metabolism · G ÷ Kf7.33mmol/L
Citrate dose33.9mmol/hr
Plasma flow Qp6.98L/hr
Extraction Ecit0.40
Dialyzer Kf2.78L/hr
Removed in effluent13.5mmol/hr
Hematocrit22.5%

Load = removal

Ecit = 0.40 CRRT intake Qp × C Citrate infusion 33.9 mmol/h Effluent 13.5 mmol/h Patient load G 20.4 mmol/h

CMax = [QACDA × CACDA ÷ (QB × (1 − Hct/100))] × (1 − Ecit) ÷ Ecit
The first term is fixed by the ACD-A : blood-flow ratio. The second depends on how much circuit plasma passes into effluent.

Ecit ≈

2Systemic citrate by liver clearance

Single-pool, fixed-volume model: citrate enters at load G and leaves by the dialyzer (Kf) and by body, mainly liver, metabolism (Kb). Uses the prescription above.

Patient

L
L
mmol/L

Projection

L/hr
hours

C(t) = C(0)·e−(Kf+Kb)t/V + G/(Kf+Kb) · (1 − e−(Kf+Kb)t/V)

Fair 15 L/hWeak 6 L/hAbsent 0 L/hPatient

Fair ≈ usual liver function, including compensated cirrhosis. Weak ≈ severely impaired but enough to avoid toxicity. Dashed verticals mark iCa checks at 2, 4 and 6 h.

Liver clearance2 h4 h6 h12 hSteady state95% of SS

mmol/L. Values ≥ 2.5 mmol/L are in red: the range where accumulation becomes a clinical concern (rising total/ionized calcium ratio).

3Sudden loss of liver clearance

Liver citrate metabolism can stop abruptly: cardiac arrest, refractory shock, acute liver failure. Compare the prescription above with a high-extraction alternative when Kb falls mid-run.

Event

L/hr
hour
L/hr
hours

Alternative CVVHDF prescription

mL/min
mL/hr
L/hr
L/hr
L/hr

Same hemoglobin, ACD-A concentration, saturation and volume as above. An editable illustration, not a protocol.

Alternative Ecit—target > 0.75
Alternative load G—mmol/hr
Alternative CMax—target < 2.5
Current prescriptionAlternative2.5 mmol/L
PrescriptionBefore eventEndCMaxTo 2.5 after event

Clinical pearls

  • Accumulation is a prescription problem first. CMax depends only on the ACD-A : QB ratio, hematocrit and Ecit. Liver clearance decides how far below CMax the patient settles.
  • Timing of detection. With fair clearance, citrate plateaus within about 3 to 4 h. With absent clearance it is still rising at 12 h, so an early normal total/ionized calcium ratio does not exclude later accumulation.
  • Shock settings. Lowering QB while keeping effluent high pushes Ecit above about 0.75 and keeps CMax below about 2.5 mmol/L even with no liver metabolism, so accumulation is self-limited.
  • CVVHD vs CVVHDF. Citrate is small (about 190 Da), so diffusion and convection clear it about equally while dialysate stays saturated. In CVVHD all extraction comes from dialysate; at high QD relative to blood flow, saturation falls below 1 and Ecit levels off (lower SD to see the effect). CVVHDF adds post-filter replacement, which raises effluent without relying on diffusion.
  • Edema changes speed, not the plateau. A larger V slows the approach to steady state but does not change the steady-state level.

Model notes: Single-pool, fixed-volume kinetic equation (Szamosfalvi et al.; validated by Zheng), as applied in Yessayan et al., BMC Nephrology 2021. Ecit is estimated as clearance-effective effluent (QD × SD + QRF + net UF + QACDA) ÷ (plasma flow + ACD-A flow), assuming citrate sieving ≈ 1 and post-dilution replacement; QRF is zero in CVVHD. Real extraction is lower with filter clotting or unsaturated dialysate. Hct ≈ Hb × 3. Calcium infusion volume and citrate–calcium complex losses are ignored. Defaults reproduce the paper’s non-shock example (QB 150 mL/min, ACD-A 300 mL/h, QD/QRF 1.2 L/h, net UF 0.2 L/h, Hb 7.5 g/dL, ECF 15 L + 7 L edema).

Clinical disclaimer — read before using

DISCLAIMER: The authors make no claim of the accuracy of the information contained herein. The calculations suggested above are inherently prone to errors and bias, and should not be a substitute for clinical judgement. The authors involved in the preparation of the site and its content should not be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. PLEASE READ THE DISCLAIMER PRIOR TO USING THE SITE. BY ACCESSING AND USING THIS SITE, YOU AGREE TO BE BOUND BY THE TERMS AND CONDITIONS OF THE DISCLAIMER.